Skip to main content

Table 1 Baseline characteristics of single acute infarction (lacunar infarction and non-lacunar infarction) and multiple acute infarctions

From: Does all single infarction have lower risk of stroke recurrence than multiple infarctions in minor stroke?

Characteristics

Single acute infarction:lacunar infarction

n = 381

Single acute infarction: non-lacunar infarction

n = 172

Multiple acute infarctions

n = 281

P value

Age,y, median (IQR)

62.6 (54.6–70.5)

61.0 (54.1–70.1)

64.8 (56.3–73.0)

0.008

Male, n (%)

261 (68.5)

105 (61.0)

193 (68.7)

0.17

Body mass index (kg/m2)

24.5 (22.7–26.2)

24.2 (22.0–26.6)

24.2 (22.0–26.2)

0.37

Medical history, n (%)

 Ischemic stroke

63 (16.5)

27 (15.7)

54 (19.2)

0.55

 TIA

5 (1.3)

4 (2.3)

9 (3.2)

0.25

 Myocardial infarction

6 (1.6)

4 (2.3)

9 (3.2)

0.38

 Angina

9 (2.4)

0 (0.0)

9 (3.2)

0.07

 Congestive heart failure

2 (0.5)

2 (1.2)

10 (3.6)

0.009

 Hypertension

243 (63.8)

109 (63.4)

184 (65.5)

0.87

 Diabetes mellitus

77 (20.2)

35 (20.3)

69 (24.6)

0.36

 Hypercholesterolaemia

45 (11.8)

20 (11.6)

32 (11.4)

0.99

Current or previous smoking, n (%)

179 (47.0)

62 (36.0)

129 (45.9)

0.046

Time to randomization, n (%)

   

0.025

  < 12 h

160 (42.0)

88 (51.2)

145 (51.6)

 

  ≥ 12 h

221 (58.0)

84 (48.8)

136 (48.4)

 

NIHSS on admission, median(IQR)

2.0 (1.0–3.0)

2.0 (2.0–3.0)

2.0 (1.0–3.0)

< 0.001

TOAST classification, n (%)

   

< 0.001

 Large-artery atherosclerosis

127 (33.3)

82 (47.7)

183 (65.1)

 

 Small-artery occlusion

254 (66.7)

0 (0.0)

0 (0.0)

 

 Undetermined cause

0 (0.0)

90 (52.3)

98 (34.9)

 

Group, n (%)

   

0.54

 Aspirin only

195 (51.2)

89 (51.7)

133 (47.3)

 

 Clopidogrel+aspirin

186 (48.8)

83 (48.3)

148 (52.7)

 

Medications, n (%)

 Antihypertensive

126 (52.5)

52 (48.2)

79 (42.9)

0.15

 Antidiabetic

37 (48.1)

17 (48.6)

30 (43.5)

0.82

 Lipid-lowering

25 (56.8)

14 (70.0)

20 (62.5)

0.60

  1. IQR Interquartile range, NIHSS National Institutes of Health Stroke Scale, TOAST Trial of Org 10,172 in Acute Stroke Treatment